Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Konecranes Performance Share Plan 2015 – directed share issue

KONECRANES PLC  STOCK EXCHANGE RELEASE  February 22, 2018 at 09.30 EETKonecranes Performance Share Plan 2015 – directed share issue The Board of Directors of Konecranes Plc has on February 21, 2018 decided on a directed share issue related to the reward payment for the performance period 2015-2017 of the Konecranes Performance Share Plan 2015. In the share issue, 49,363 Konecranes Plc shares held by the company are conveyed without consideration to the key employees participating in the plan in accordance with the terms and conditions of the plan. More detailed information about the

The GABA/Diamyd®   trial in the US fully recruited this summer

In the placebo-controlled combination trial GABA/Diamyd® conducted at University of Alabama at Birmingham, US, 82 patients have now been included, of which 48 have completed the entire trial. No serious side effects have been reported and the treatment appears to be safe. The trial is expected to be fully recruited this summer.GABA/Diamyd® is a three-arm, double-blind and placebo-controlled trial including a total of 95 children and adolescents between 4 and 18 years, recently diagnosed with type 1 diabetes. The patients are randomly assigned to one of three treatment groups: a) two

Net Gaming issues new financial objectives

Following recent acquisitions and the refinancing arranged in autumn 2017, the Management and Board of Net Gaming have conducted a strategic review and adopted an updated strategy. As a result, the Company is issuing new financial targets.Net Gaming sees significant opportunities to grow its business in the next few years, both organically and through acquisitions. To take advantage of the growth opportunities that the Company sees, the growth strategy been reviewed and new financial targets have been produced. “Net Gaming has changed considerably over the last 1.5 years and we now have

Share transactions related to Oriflame’s share incentive plan

As already announced in Oriflame’s 2017 year-end report, the Board of Oriflame Holding AG has in accordance with the terms and conditions of the 2014 and 2015 share incentive plans decided to deliver achievement shares to key employees of the Oriflame Group. The allotment of the achievement shares has now been completed. Following the reception of achievement shares, members of Group Management have sold parts of their allotment to inter alia cover for their related tax obligations. After the transactions, the individual holdings of Oriflame shares by all Group Management members have

AQ Group has been selected to manufacture electrical distribution systems to Scania’s bus chassis

AQ Wiring Systems in Lithuania has been nominated by Scania to manufacture the complete electrical distribution system for the Scania bus chassis. The deliveries will start in the middle of 2019. The contract value is confidential but will be a good contribution for the group´s strive for organic growth from 2019 onwards. This means that AQ Wiring Systems confirms its leading position as the number one producer of electrical distribution systems for buses in Europe. “This is a major milestone for AQ Group”, says Claes Mellgren, CEO of AQ Group. “This is the first time that we can start

Restructuring at AQ Welded Structures in Ludvika

AQ Welded Structures AB is starting negotiations with the unions about its intentions to close down the manufacturing site in Ludvika. The background to the closure is that the company has generated losses for several years and when one of the customers has announced a move of a product family abroad, which negatively affects the sales volume the company doesn't see a profitable future. The manufacturing can be moved to other companies in the group to secure deliveries to the customers. “The site has a long tradition and the technical competence of the employees is high. However, in order

Proposal by the Nomination Committee of AQ Group AB for election of Members of the Board of Directors

AQ’s Nomination Committee proposes Patrik Nolåker as new Chairman of the Board of Directors. Between 1988-2009 Patrik held a number of leading positions within Atlas Copco and ABB. During 2010-2012 he worked as CEO of Alimak Hek Group AB and 2012-2016 as CEO of Dywidag-Systems International. He is today Board member of AQ Group AB, Systemair AB, Outotec Oyj and Dywidag- Systems International. The Nomination Committee proposes Annika Johansson-Rosengren as new Board member. Annika is today HR Director Region North Bombardier Transportation. During 1995-2014 she had various HR leading

New President and CEO of AQ Group

The Board of Directors of AQ Group has appointed Anders Carlsson as new President and CEO. Anders will assume the position latest September 1, replacing one of AQ's founders, Claes Mellgren who will step down after eight successful years as CEO.’’We are pleased to present Anders Carlsson as our next President and CEO. Anders is an experienced and competent leader who, in his different roles in ABB, has a proven understanding and track record for new technologies, production and creation of growth. The board and I are convinced that Anders is the right person to further develop AQ Group to

Eltel Group: Full-year report January–December 2017

October–December 2017 ·Group net sales decreased 3.3% to EUR 374.2 million (387.1), mainly as a result of divestments and on-going discontinuation of non-core operations and unprofitable contracts, in line with the transformation strategy ·Net sales in the Core business, including segment Power and segment Communication, decreased 3.0% to EUR 338.5 million (348.9). The decrease is mainly explained by divestments of operations in Latvia and Estonia, termination of the UK business and divestment of part of the Polish operations ·Adjusted for divested and discontinued

AQ Group: Year-end report 2017

Full year 2017 in brief · Net sales increased by 22 % to SEK 4 020 million (3 289) · Operating profit (EBIT) decreased by 6 % to SEK 263 million (281) · Profit after financial items (EBT) decreased by 8 % to SEK 256 million (279) · Profit margin before tax (EBT%) 6.4 % (8.5) · Cash flow from operating activities decreased by 52% to SEK 140 million (290) · Equity ratio 61 % (60) · Earnings per share after tax decreased by 14 % to SEK 11.14 SEK (13.01) · The Board of Directors proposes a dividend of 2.75 SEK (2.75) Fourth quarter, October – December 2017in brief

Sobi™ publishes its report for the fourth quarter and full-year 2017

Swedish Orphan Biovitrum AB (publ)  (Sobi™) today announces its results for the fourth quarter and full-year 2017. Total revenues for the full-year amounted to SEK 6,511 M, an increase of 25 per cent. Revenues for the quarter were SEK 1,875 M, an increase of 45 per cent. Product sales for the full-year amounted to SEK 5,917 M, an increase of 30 per cent, and for the quarter SEK 1,746 M, an increase of 53 per cent. Business highlights Q4 2017 · Continued strong growth driven by successful launches of Elocta® and Alprolix® · Alprolix approved in Saudi Arabia

Change of the Nomination Committee in Proact IT Group AB

As previously announced, a Nomination Committee, in accordance with the decision of the Proact Annual General Meeting 2017, has been appointed to work out proposals to be submitted at the Company's Annual General Meeting 2018. The Nomination Committee shall be represented by the company's four largest shareholders regards to voting rights as well as the Chairman of the Board. Swedbank Robur Fonder has divested its entire shareholding in Proact IT Group AB on February 12, 2018. At the same time, as of 12 February 2018, TVF TopCo Limited acquired shares in Proact IT Group AB, which means

Sivers IMA presents world class mmWave 5G RF consortium and WiGig for FWA at MWC, 2018

The Mobile World Congress (MWC) will take place in Barcelona, starting February 26th, and Sivers IMA will attend the world’s largest gathering for the mobile industry to engage with customers to show and discuss around new products and the future of millimeter wave technology.This year Sivers IMA’s presence at MWC is about two main offerings. To show and demonstrate the best performing WiGig RFIC in the market, with a unique feature set for 60 GHz WiGig infrastructure applications such as Fixed Wireless Access (FWA). Sivers IMA will also share information about the ongoing development of 5G

TC TECH Sweden AB (publ) - Summarized Financial Statements December 31 2017

Net sales amounted to 0 (0) TSEK in the fourth quarter of 2017.  Net profit/loss totalled -8 116 (-5 046) TSEK in the fourth quarter of the year.   Cash flow from operating activities was -5 208 (-3 591) TSEK in the period from October 1st to December 31 2017.   Net sales amounted to 3 141 (0) TSEK in the full year 2017, While net profit/loss totalled -23 784 (-22 816) TSEK in the full year 2017.  Cash flow from operating activities was -15 182 (-17 945) TSEK in the full year 2017.TC TECH Sweden AB (publ) has received a patent approval in Taiwan for the patent application ”Device and

YEAR-END REPORT 2017

THE FULL YEAR AND FOURTH QUARTER · Net sales amounted to MSEK 657.6 (347.3), whereof the fourth quarter MSEK 238.7 (96.5), representing an increase of 89 percent for the year and 147 percent for the quarter. · Adjusted EBITDA amounted to MSEK 169.3 (51.7), whereof the fourth quarter MSEK 41.8 (28.9) representing a margin of 25.7 percent (14.9) for the year and 17.5 percent (29.9) for the fourth quarter. The relatively lower margin in the fourth quarter was primarily due to the lower adjusted EBITDA margin at Weifa. Restructuring to achieve synergy effects on operating costs is

Oncopeptides AB Year-end report 2017

Stockholm, Sweden – Oncopeptides AB (Nasdaq Stockholm; ONCO) today announced the Year-end report 2017.“With increasing clinical data the possible role for Ygalo® in helping patients with myeloma becomes clearer”  SUMMARY OF Q4 October 1st – December 31st 2017 · Net sales amounted to 0.0 (0.0) MSEK · Loss for the period was 66.7 (loss: 51.1) MSEK · Loss per share, before and after dilution, was 1.68 (loss: 1.84) SEK · On December 31st cash and cash equivalents amounted to 404.1 (40.3) MSEK Significant events during the period October 1st to December 31st 2017 ·

Internationella Engelska Skolan 2017/2018

Interim Report - (1 July - 31 December 2017)Progress of operations in the second quarter (October-December) · Total operating income increased by 12.6% year on year, mainly due to a larger student base, and amounted to MSEK 613.2 (544.4) · The number of students in the Swedish operation at the end of the quarter was 24,000 (21,407) · There were around 161,000 registrations on waiting lists at the end of the quarter, an increase of some 6,000 (5%) on 30 September 2017, and an increase of some 28,000 (21%) on the corresponding point of the previous year · Adjusted EBIT for the

WULFF GROUP PLC'S FINANCIAL STATEMENTS RELEASE JANUARY 1 – DECEMBER 31, 2017

FINANCIAL STATEMENTS RELEASE      FEBRUARY 22, 2018 at 9.00 A.M.  EBITDA and operating profit grew in the final quarter of the financial year  This is a summary of Wulff Group Plc's Financial Statements Release January 1 - December 2017. The complete report is attached to this stock exchange release as a pdf-file. The report is also available at the website www.wulff-group.com. 1.10. – 31.12.2017 BRIEFLY · Net sales totalled EUR 15.8 million (15.8), up 0.1% · EBITDA and comparable EBITDA were EUR 0.4 million (0.3), up 20.6% · Operating profit (EBIT) and comparable

Digia Plc's Annual Report 2017 published

Digia PlcStock exchange release22 February 2018 at 9:00 am Digia Plc's Annual Report 2017 published Digia's Annual Report for the year 2017 has been published in Finnish and in English on company's website, www.digia.com. The Annual Report contains the Board of Directors' report and the Auditors' report, the Financial Statements 2017 and the Corporate Governance Statement and Remuneration Report. A PDF file of the Annual Report 2017 is attached to this release. For more information, please contact:Maarit Mikkonen, Communications Manager, Digia Plc, tel. +358 40 562 2282

Ossur Hf : Final agenda and proposals for the Annual General Meeting 8 March 2018

Announcement no. 12/2018Reykjavik, 22 February 2018  Final agenda and proposals Enclosed is the final agenda and proposals for Össur's Annual General Meeting, to be held on Thursday 8 March 2018. The meeting will be held at Össur's headquarters Grjótháls 5, Reykjavik, Iceland. No changes have been made to the previously announced agenda and proposals. Further information David HreidarssonInvestor Relationsdohreidarsson@ossur.com+354 515 1380 About Össur Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that helps people live a life without

Konecranes Employee Share Savings Plan 2014-2015 – directed share issue

KONECRANES PLC  STOCK EXCHANGE RELEASE  February 22, 2018 at 09.00 EETKonecranes Employee Share Savings Plan 2014-2015 – directed share issueThe Board of Directors of Konecranes Plc has on February 21, 2018 decided on a directed share issue related to the reward payment for the Savings Period 2014-2015 of Konecranes Employee Share Savings Plan.In the share issue, 17,995 Konecranes Plc shares held by the company are conveyed without consideration to the employees participating in the plan in accordance with the terms and conditions of the plan. More detailed information about the

ContextVision Sees Strong Sales, Major Progress Within R&D in Q4 2017

STOCKHOLM - February 22, 2018 - ContextVision, a medical technology software company specializing in image analysis and artificial intelligence, reports a sustainable business and progress of the ambitious AI-based research and development program. The company has a strong market position and sales ended at 22,5 MSEK in Q4 2017, compared to 24,9 MSEK the previous year. The difference is explained by the extraordinary order for field upgrades within MRI during 2016. ContextVision made up for most of this difference on a full-year basis and sales ended at 80,5 MSEK versus 81,9 MSEK last

IK Investment Partners closes EUR 550 million Small Cap II Fund

IK Investment Partners (“IK”), a leading Pan-European private equity advisory group, is pleased to announce that it has closed the IK Small Cap II Fund (“IK Small Cap II” or “the Fund”) at its hard cap of EUR 550 million. IK Small Cap II was substantially oversubscribed and allocated to existing IK platform investors.The Fund is nearly double the size of IK’s maiden small cap fund, which closed at its hard cap of EUR 277 million in March 2016. IK Small Cap I Fund has invested in 12 companies of which three have been successfully realised to date.  IK Small Cap II will continue to target

There are no items matching the current filter
There are no more items matching the current filter
Back to top